Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medical Devices To Draw Big Pharma Into India As Sector Poised To Double By 2012 - PwC Report

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - India's medical device market is set to nearly double to around $5 billion by 2012 from $2.75 billion in 2008, spurred by improving healthcare infrastructure including new hospitals, clinics, and laboratories, along with new approaches to healthcare delivery like telemedicine

You may also be interested in...



AdvaMed Pushes For Separate Indian Medical Devices Law

AdvaMed, the powerful industry lobby group representing US-based medical device companies, claims the growth of the sector in India will be stymied if it is regulated under the country’s Drugs and Cosmetics Act. Independent dedicated legislation would enable fair treatment and harmonize the devices industry with global standards, it argues.

India’s Device Sector At A Crossroads: Will New Policy Push Growth?

The $4.4 billion medical device sector in India has plenty of reasons to grow, but to do so will require a policy framework conducive to innovative products and contentious issues like pricing will need to be resolved by evidence-based decisions, industry says.

Medical Device Market In India Heads Toward Boom; MNCs Control Majority Of High-end Market

MUMBAI - Growing investment in private sector infrastructure and increased healthcare funding from the government have led to a 15-20 percent rise in demand for medical devices and equipment in India

UsernamePublicRestriction

Register

OM004559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel